Stay updated on BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Sign up to get notified when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.
Latest updates to the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check26 days agoChange DetectedNew guidelines for sharing raw clinical study data and documents sponsored by Boehringer Ingelheim have been added, detailing exceptions and providing a link for more information, while several previous access criteria and sharing agreements have been removed.SummaryDifference11%
- Check33 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference4%
- Check41 days agoChange DetectedThe study has been terminated as of November 5, 2024, with new results posted detailing participant groups, drug-related adverse events, and various changes from baseline in neutrophil activity and counts, while previous entries regarding completed status and specific locations have been removed.SummaryDifference44%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.